Bausch Health Companies Inc. buy tamam
Start price
14.12.18
/
50%
€21.56
Target price
17.12.18
€29.80
Performance (%)
-12.11%
End price
17.12.18
€18.95
Summary
This prediction ended on 17.12.18 with a price of €18.95. The prediction for Bausch Health Companies Inc. disappointed with a performance of -12.11%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bausch Health Companies Inc. | 10.628% | 10.628% | -12.882% | -21.560% |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
Comments by tamam for this prediction
In the thread Bausch Health Companies Inc. diskutieren
Bausch Health Companies Acquires 2 Possible Blockbuster Drugs for $200 Million from SGYP
tamam stimmt am 14.12.2018 der Buy-Einschätzung von Subdi mit dem Kursziel 29,8$ zu.
Überschrift: Name change to Bausch Health Companies Inc.
(Stop Loss Kurs erreicht)
Stopped prediction by tamam for Bausch Health Companies Inc.
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€18.10
18.12.18
18.12.18
€29.80
19.12.18
19.12.18
0.00%
19.12.18
19.12.18
